TNF and inflammatory bowel disease: Current treatment for IBD was: 5-ASA (255 [33.8%]), anti-TNF (161 [21.4%]), no treatment (106 [14.1%]), non-anti-TNF biologic drugs (82 [10.9%]), immunosuppressant (74 [9.8%]), immunosuppressant + anti-TNF (39 [5.2%]), steroids (10 [1.3%]), immunosuppressant + non-anti-TNF biologic drug (7 [0.9%]), tofacitinib (6 [0.8%]) and other (14 [1.8%]).